CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cash Surrender Value of Life Insurance
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Cash Surrender Value of Life Insurance of $83.27 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:CashSurrenderValueOfLifeInsurance · last filed 2026-08-05
- 2026-06-27: Cash Surrender Value of Life Insurance $83.27M.
- 2026-03-28: Cash Surrender Value of Life Insurance $64.38M.
- 2025-12-27: Cash Surrender Value of Life Insurance $66.32M; Cash Surrender Value of Life Insurance as first filed $66.30M.
- 2024-12-28: Cash Surrender Value of Life Insurance $55.80M.
| Period end | Cash Surrender Value of Life Insurance | Cash Surrender Value of Life Insurance as first filed |
|---|---|---|
| 2026-06-27 | $83.27M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $64.38M 10-Q · filed 2026-05-07 | |
| 2025-12-27 | $66.32M 10-Q · filed 2026-08-05 | $66.30M 10-K · filed 2026-02-18 |
| 2024-12-28 | $55.80M 10-K · filed 2026-02-18 | |
| 2023-12-30 | $48.40M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $41.90M 10-K · filed 2024-02-14 | |
| 2022-09-24 | $39.94M 10-Q · filed 2022-11-02 | |
| 2022-06-25 | $42.12M 10-Q · filed 2022-08-03 | |
| 2022-03-26 | $47.26M 10-Q · filed 2022-05-04 | |
| 2021-12-25 | $51.00M 10-K · filed 2023-02-22 | $51.05M 10-K · filed 2022-02-16 |
| 2021-09-25 | $49.17M 10-Q · filed 2021-11-03 | |
| 2021-06-26 | $48.72M 10-Q · filed 2021-08-04 | |
| 2021-03-27 | $46.26M 10-Q · filed 2021-05-04 | |
| 2020-12-26 | $43.83M 10-K · filed 2022-02-16 | |
| 2020-09-26 | $38.34M 10-Q · filed 2020-10-29 | |
| 2020-06-27 | $36.00M 10-Q · filed 2020-08-05 | |
| 2020-03-28 | $31.62M 10-Q · filed 2020-05-07 | |
| 2019-12-28 | $38.21M 10-K · filed 2021-02-17 | |
| 2019-09-28 | $35.86M 10-Q · filed 2019-11-06 | |
| 2019-06-29 | $35.82M 10-Q · filed 2019-07-31 | |
| 2019-03-30 | $34.94M 10-Q · filed 2019-05-07 | |
| 2018-12-29 | $32.34M 10-K · filed 2020-02-11 | |
| 2018-09-29 | $35.92M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $34.92M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $33.94M 10-Q · filed 2018-05-10 | |
| 2017-12-30 | $34.01M 10-K · filed 2019-02-13 | |
| 2017-09-30 | $32.74M 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $31.53M 10-Q · filed 2017-08-09 | |
| 2017-04-01 | $30.76M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $29.46M 10-K · filed 2018-02-13 | |
| 2016-09-24 | $28.84M 10-Q · filed 2016-11-02 | |
| 2016-06-25 | $27.60M 10-Q · filed 2016-08-03 | |
| 2016-03-26 | $27.13M 10-Q · filed 2016-05-04 | |
| 2015-12-26 | $27.55M 10-K · filed 2017-02-14 | |
| 2015-09-26 | $26.46M 10-Q · filed 2015-11-04 | |
| 2015-06-27 | $28.24M 10-Q · filed 2015-07-30 | |
| 2015-03-28 | $27.85M 10-Q · filed 2015-04-30 | |
| 2014-12-27 | $27.60M 10-K · filed 2016-02-12 | |
| 2014-09-27 | $27.27M 10-Q · filed 2014-10-30 | |
| 2014-06-28 | $27.44M 10-Q · filed 2014-08-07 | |
| 2014-03-29 | $26.78M 10-Q · filed 2014-04-30 | |
| 2013-12-28 | $26.51M 10-K · filed 2015-02-17 | |
| 2013-09-28 | $25.63M 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $24.06M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $24.32M 10-Q · filed 2013-05-08 | |
| 2012-12-29 | $25.24M 10-K · filed 2014-02-25 | |
| 2012-09-29 | $20.50M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $20.27M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $25.71M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $25.06M 10-K · filed 2013-02-27 | |
| 2011-09-24 | $24.17M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $22.89M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $31.05M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |